Worry Free Beating Medical Technology (Shenzhen) Co., Ltd. focuses on cardiovascular interventional devices and has established a product matrix covering the integrated diagnosis and treatment of patent foramen ovale, seeking overseas rights cooperation w
Supplier Advantages: Worry Free Beating Medical Technology (Shenzhen) Co., Ltd., focuses on interventional treatment for structural heart disease and has received NMPA approval for two products: an occluder delivery system and an atrial septal measurement balloon catheter. The company’s self-developed bioabsorbable cardiac occluder has passed the special review for innovative medical devices by the state and has been awarded multiple honors. Established in 2021, the company has applied for over 100 domestic and international patents and developed an integrated PFO diagnosis and treatment solution, becoming the world's first enterprise to offer a complete solution. It has completed angel round and Pre-A round financing, with a cumulative production value reaching 5 million yuan, and is projected to exceed 120 million yuan in revenue within the next two years. The company is committed to technological innovation to improve patient quality of life.
| Published by | Worry Free Beating | Department | -- |
|---|---|---|---|
| Region | Guangdong,China | Budget | -- |
| Validity | Expires in 34 days | ||
1. Requirements Description
Seeking overseas well-known medical device brands for overseas rights cooperation. Interested parties are welcome to communicate.
2. Product Overview
Worry Free Beating Medical Technology (Shenzhen) Co., Ltd. has obtained NMPA approval for two products:
Occluder Delivery System (Registration Certificate No.: GuoXieZhuZhun 20243030961)——This product is suitable for delivering atrial septal defect occluders and patent foramen ovale occluders via the femoral vein, and delivering patent ductus arteriosus occluders and ventricular septal defect occluders via the femoral artery to the implantation site.
Atrial Septal Measurement Balloon Catheter (Registration Certificate No.: Guo Xie Zhu Zhun 20243032084)——This product is used to measure the defect in the atrial septum, and is suitable only for patients who require precise measurement of the defect to correctly select the occluder size.
In addition, the company's independently developed degradable cardiac occluder has not only passed the special review of the National Innovative Medical Device, but also won several honors with its excellent product innovation capabilities, includingSecond Prize in the Biomedical Industry Final of the 15th China Shenzhen Innovation and Entrepreneurship Competition Pingshan Preliminary Zone and the 2023 "Pingshan High-Tech Zone Cup" Innovation and Entrepreneurship Competition、Outstanding Award of the 15th China Shenzhen Innovation and Entrepreneurship Competition, and successfully selectedTop 100 List of VBEF 2024 Innovative Medical and Health Industry Products.
3. Company Profile
Worry Free Beating Medical Technology (Shenzhen) Co., Ltd. was established in 2021 as a national high-tech enterprise specializing in the field of interventional treatment for heart diseases, particularly structural heart diseases. The company is committed to building a globally leading integrated PFO (patent foramen ovale) diagnosis and treatment solution, filling industry gaps and driving medical technology innovation. Currently, the company has applied for more than 100 domestic and international patents and has developed multiple innovative products around PFO diagnosis and treatment, including occluder delivery systems, atrial septal measurement balloon catheters, bioresorbable cardiac occluders, interventional cardiac suturing devices, and fully automatic cardiac angiography detectors. It has taken the lead in achieving a comprehensive closed-loop for PFO diagnosis and treatment, becoming the world's first technology innovation enterprise to provide a complete solution.
At the capital level, the company has completedAngel Round and Pre-A Round Financing, including well-known institutions such as Force Link Innovation, Qifu Capital, and Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ), demonstrating strong industry competitiveness and market recognition. Since its establishment, the company has achieved a total production value of 5 million yuan, and it is expected that the revenue scale will exceed 120 million yuan in the next two years.
Worry Free Beating Medical Technology (Shenzhen) Co., Ltd. always adheres to "Innovation, Collaboration, Dedication, and Win-Win"The core values, with"Maximizing patients' quality of life and perfecting the last line of defense for life" is the mission, aspiring to grow into a leader in innovative cardiac medical devices within the next decade. In the future, the company will continue to advance technological innovation, empower heart health through technology, and help the industry reach new heights.